Methotrexate in rheumatoid arthritis : A 2 year experience at a university hospital in Pakistan

Journal of the Pakistan Medical Association

Volumn 48, Issue 1, 1998, Pages 3-6

  Ali, Azra A ^a   Iqbal, M Perwaiz ^b   Hussain, M Azmat ^a   Mehboobali, N ^b   Beg, Javed A ^b   Rahbar, M Hussain ^b  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CHLOROQUINE; GOLD; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GOLD; HOSPITALS, UNIVERSITY; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PENICILLAMINE; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0031604275     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gibson, T. and Hameed, K. The prevalence of rheumatoid arthritis in two urbanized Pakistani populations. Scientific Abstracts. 57th meeting of the American College of Rheumatology, Atlanta, American College of Rheumatology, 1993, p. A-l 7.
2. Gardner, G. and Furst, D.E. Disease modifying antirheumatic drugs: Potential effects in older patients. Drugs Aging, 1995;7:420-37.
3. Felson, D.T., Anderson, J.J. and Meenan, R.F. The comparative efficacy of and toxicity of second line drugs in rheumatoid arthritis. Arthritis Rheum., 1990;33:1449-61.
4. Felson, D.T., Anderson, J.J. and Meenan, R.F. Use of short-term efficacy/toxicity trade offs to select second line drugs in rheumatoid arthritis. Arthritis Rheum., 1992;35:1117-25.
5. Weinblatt, M.E., Coblyn, J.S., Fox, D.A. et al. Efficacy of low- dose methotrexate in rheumatoid arthritis. N. Engl. J. Med., 1985;312:818-22.
6. Williams, H.J., Willkens, R.F., Samuelson, C.O.et al. Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: A controlled clinical trial. Arthritis Rheum., 1985;28:721-30.
7. Anderson, P.A., West, S.G., O'Dell, J.R. ct al. Weekly pulse methotrexate in rheumatoid arthritis: Clinical and immunologic effects in a randomized, double-blind study. Ann. Intern. Med., 1985;103:489-96.
8. Furst, D.E., Kochnke, R., Burmeister, L.F. et al. Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J. Rheumatol., 1989;16:313-20.
9. Pinals, R.S., Masi, A.T., Larsen, R.A. el al. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum , 1981;24:1308-15.
10. Steinsson, K., Weinstein, A., Korn, J. et al. Low-dose methotrexate in rheumatoid arthritis. J. Rheumatol., 1982;9:860- 6.
11. Conghan, P.G., Quin, D.I., Brooks, P.M. et al. Hazards of low dose methotrexate. Aust. N.Z.J. Med., 1995;25:670-673.
12. Wolfe, R., Hawley, D.J. and Cattey, M.A. Termination of slow acting antirheumatic therapy in rheumatoid arthritis. A 14 year prospective evaluation of 1017 consecutive starts. J. Rheumatol., 1990;17:994-1002.
13. Winblatt, M.E. and Maier, A.L. Long term experience with low dose weekly methotrexate in rheumatoid arthritis. J. Rheumatol., 1990;17:33-38.
14. Buchbinder, R.,Hall, S., Sambrook, P.N. et al. Methotrexate therapy in rheumatoid arthritis. A life table review of 587 patients treated in community practice. J. Rheumatol., 1993;20:639-44.
15. Sandoval, D.M., Alarcon, G.S. and Morgan, S.L. Adverse events in methotrexate treated rheumatoid arthritis. Br. J. Rheumatol., 1995;34(suppl.2):49-56.
16. McKendry, R.J.R. and Dale, P. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis. J. Rheumatol., 1993;20:1850-56.
17. Alorcon, G.S , Tracey, I.C. and Blackburn, W.D. Methotrexate in rheumatoid arthritis-Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum., 1989;32:671-76.
18. Sany, J., Anaya, J.M., Lussiez, V. et al. Treatment of rheumatoid arthritis with methotrexate: A prospective open long-term study of 191 cases. J. Rheumatol., 1991;18:1323-27.
19. Weinstein, A., Marlowe, S., Korn, J. et al. Low-dose methotrexate treatment of rheumatoid arthritis. Long term observations Am. J. Med., 1985;79:331-37.
20. Kremer, J.M., Alarcon. G.S., Lightfoot, R.W. et al. Methotrexate for rheumatoid arthritis. Arthritis Rheum., 1994,37:316-328.
21. Fehlauer, C.S., Canon, C.W.,Cannon,G.W.et al.Methotrexate therapy in rheumatoid arthritis. 2 years retrospective follow-up study. J. Rheumatol., 1989;16:307-312.
22. Weinblatt, M.E. Efficacy of methotrexate in rheumatoid arthritis. Br. J. Rheumatol., 1995;34(suppl.2):43-48.
23. American College of Rheumatology Adhoc Committee on Clinical Guidelines: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum., 1996;39:713-22.